Companies /Basic Materials

Americas Silver Corp

NYSE MKT: USAS Other Industrial Metals & Mining
$4.23
▲ $0.06 (+1.32%) today
Markets closed · 6:10pm ET

USAS at a Glance

Valuation
Market cap
$1.5B
Profitability
Revenue (TTM)
$181.6M
Profit margin
-26.3%
EPS (TTM)
$-0.19
Price
52-week range
$4 – $11
Street target
$9.25
Earnings
Next report
Nov 9, 2026

Headquartered in Toronto, ON Fiscal year ends December NYSE MKT: USAS americas-gold.com

About Americas Gold & Silver

Americas Gold and Silver Corporation is a North American silver-focused mining company engaged in the exploration, development, and production of precious and base metals. The company operates the Galena Complex in Idaho's Silver Valley, which includes the Galena mine, the recently acquired Crescent mine, the Coeur mine, and the Caladay development project, producing silver, lead, copper, and antimony. It also operates the Cosalá Operations in Sinaloa, Mexico, encompassing the EC120 silver-copper project (which declared commercial production in January 2026) and the San Rafael silver-zinc-lead mine. The Galena Complex has produced over 230 million ounces of silver over more than sixty years. The company holds the Relief Canyon gold mine in Nevada (on care and maintenance) and the San Felipe development property in Sonora, Mexico. A joint venture with United States Antimony Corporation was formed in February 2026 to construct an antimony processing facility in Idaho, targeting domestic U.S. supply of this critical mineral with defense and energy applications. The company generates revenue primarily from concentrate sales of silver, copper, lead, zinc, and antimony. Shares trade on the TSX under 'USA' and NYSE American under 'USAS'. Updated

USAS Coverage

Frequently Asked Questions

What does Americas Gold & Silver do?

Americas Gold and Silver Corporation is a North American silver-focused mining company engaged in the exploration, development, and production of precious and base metals.

What is the USAS stock price target?

The Wall Street consensus 12-month price target for USAS is $9.25.